Trump bats for Indian origin R

INTERNATIONAL

Trump bats for Indian origin Ramaswamy

Once he falls after India with heavier import duty taxation, on the other side President Donald Trump surprisingly hailed his Republican comrade Vivek Ramaswamy as ‘something special’ today and endorsed him for Ohio Governor race, which infused political sensation, awfully.

Ramaswamy, an entrepreneur-turned-politician, ran an unsuccessful campaign in last year’s Republican presidential primary. After suspending his bid, he endorsed Donald Trump and quickly became one of his close confidants.

Ramaswamy aims to make Ohio the top state for business growth, education, and innovation. He seeks to promote capitalism and meritocracy, reduce regulations, and enhance security, his confidential sources said.

Trump threw his weight behind Indian-origin Republican leader Vivek Ramaswamy, saying: "Ramaswamy will be a 'great' governor of Ohio."

In a post on Truth Social on Friday, Trump stated: "Vivek Ramaswamy will be a GREAT Governor of Ohio, and has my Complete and Total Endorsement – HE WILL NEVER LET YOU DOWN!"

"I know Vivek well, competed against him, and he is something SPECIAL. He is Young, Strong, and Smart!" Trump said.

Calling him a “very good person”, the US President said Ramaswamy "truly loves" the US.

“As your next Governor, Vivek will fight tirelessly to grow the economy, cut taxes and regulations, promote MADE IN THE U.S.A., champion American energy DOMINANCE, keep our now very secure border, SECURE, stop migrant crime, strengthen our military/veterans, ensure LAW AND ORDER, advance election integrity, and protect our always under siege Second Amendment.”

Ramaswamy, 40, thanked Trump for his support and endorsement.

“Thank you, President Trump! Let’s make Ohio greater than ever,” he stated.

But, who is this Vivek Ramaswamy?

Born and raised in Cincinnati, Ohio, Vivek Ramaswamy earned a degree in Biology from Harvard University and later obtained a J.D. from Yale Law School. He went on to found the biotech firm Roivant Sciences, where he oversaw the development of five drugs that eventually received FDA approval.